Aadi Bioscience is a series c plus startup. 1 investor tracked. Status: possibledead.
Based in the United States, Aadi Bioscience is a startup founded in 2015. Its most recent tracked round is Series-c-plus. Brouky records 1 investor associated with the company.
Aadi Bioscience is a biopharmaceutical company focused on developing precision therapies for genetically-defined cancers with alterations in mTOR pathway genes, initially commercializing FYARRO for advanced malignant PEComa before pivoting to antibody-drug conjugates (ADCs).
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.